Antimicrobial susceptibility of Gram-negative organisms isolated from patients hospitalized in intensive care units in United States and European hospitals (2009–2011)

Sader, Hélio S.; Farrell, David J.; Flamm, Robert K.; Jones, Ronald N.

doi:10.1016/j.diagmicrobio.2013.11.025

Cited by 209 publications

(198 citation statements)

References 22 publications

Supporting

Mentioning

167

Contrasting

Unclassified

Order By: Relevance

“…68,69 Current prevalence of ESBL production in bacteremic isolates in US varies between 8.1% to 13.7%. 70,71 Isolates from ICU patients and patients with hematological malignancies showed higher resistance rates. 66,71 In those countries where antimicrobial use is not strictly controlled, high prevalence of ESBL production has been reported in community-settings as well.…”

Section: Escherichia Colimentioning

confidence: 99%

“…70,71 Isolates from ICU patients and patients with hematological malignancies showed higher resistance rates. 66,71 In those countries where antimicrobial use is not strictly controlled, high prevalence of ESBL production has been reported in community-settings as well. Examples including countries in Asia including India 69 76 and Romania 77 provide information about prevalence of ESBLs for both CA and HCA isolates of E. coli in various countries.…”

Section: Escherichia Colimentioning

confidence: 99%

See 1 more Smart Citation

Epidemiology of antimicrobial resistance in bloodstream infections

2016

View full text Add to dashboard Cite

Antimicrobial resistance in bacterial pathogens is a worldwide challenge leading high morbidity and mortality in clinical settings. Multidrug resistant patterns in gram-positive and -negative bacteria have resulted in difficult-to-treat or even untreatable infections with conventional antimicrobials. Since the early identification of causative microorganisms and their antimicrobial susceptibility patterns in patients with bacteremia and other serious infections is lacking in many healthcare institutions, broad spectrum antibiotics are liberally and mostly unnecessarily used. Such practice has, in turn, caused dramatic increases in emerging resistance and when coupled with poor practice of infection control, resistant bacteria can easily be disseminated to the other patients and the environment. Thus, availability of updated epidemiological data on antimicrobial resistance in frequently encountered bacterial pathogens will be useful not only for deciding on empirical treatment strategies, but also devising an effective antimicrobial stewardship program in hospitals.

show abstract

Section: Escherichia Colimentioning

confidence: 99%

Section: Escherichia Colimentioning

confidence: 99%

Epidemiology of antimicrobial resistance in bloodstream infections

2016

View full text Add to dashboard Cite

show abstract

“…Recent SENTRY Antimicrobial Surveillance Program data also show that more than 95% of Acinetobacter spp. isolates from Europe, China, and the United States are susceptible to colistin [63,64]. In South Korea, colistin resistance rates among A. baumannii isolates have been estimated to be 7.0% and 2.4% [4,8].…”

Section: P233s A)mentioning

confidence: 99%

Old drug, new findings: colistin resistance and dependence of Acinetobacter baumannii

Choi

Lee

2017

Precis Future Med

View full text Add to dashboard Cite

Colistin is an old drug, and its use has recently resurged because of increasing antibiotic resistance in gram-negative bacteria such as Acinetobacter baumannii. Although the colistin resistance rates in gram-negative bacteria are currently not high, many colistin-resistant isolates are being identified and the possibility of horizontal transmission of colistin resistance has increased because of the plasmid-borne colistin resistance gene mcr-1 (mobilized colistin resistance). In this review, we have discussed colistin resistance in A. baumannii. In addition, we have reviewed an abnormal phenomenon called colistin dependence in A. baumannii.

show abstract

“…However, the resistance rates for amikacin and fosfomycin were high, 10% and 17.5%, respectively [49]. Higher resistance rates were found in non-intensive care units in the United States of America and Europe for imipenem (22% and 6.9%) and amikacin (18.9% and 19.1%), respectively [50].…”

Section: Discussionmentioning

confidence: 99%

Detection of High Prevalence of TEM/SHV/CTX-M Genes in ESBL Producing and Multidrug Resistant Klebsiella Pneumoniae and Klebsiella Oxytoca

Sb¹,

Pietropaoli²,

Sn³

et al. 2016

J Clin Diagn Res

View full text Add to dashboard Cite

Background: Klebsiella spp. are Enterobacteriaceae frequently isolated from pathological specimens during urinary tract infections, bloodstream infection, and pus. They are becoming more and more resistant to antibiotics and challenging treatment options. β-lactamases are a great variety of enzymes capable of inducing resistance to β-lactams. The objective of this study was to identify extended-spectrum-β-lactamase (ESBL) genes in Klebsiella spp. strains isolated from various specimens in Lomé, Togo.

show abstract

Antimicrobial susceptibility of Gram-negative organisms isolated from patients hospitalized in intensive care units in United States and European hospitals (2009–2011)

Cited by 209 publications

References 22 publications

Epidemiology of antimicrobial resistance in bloodstream infections

Epidemiology of antimicrobial resistance in bloodstream infections

Old drug, new findings: colistin resistance and dependence of Acinetobacter baumannii

Detection of High Prevalence of TEM/SHV/CTX-M Genes in ESBL Producing and Multidrug Resistant Klebsiella Pneumoniae and Klebsiella Oxytoca

Contact Info

Product

Resources

About